Association study for single nucleotide polymorphisms in the CYP17A1 gene and polycystic ovary syndrome

被引:31
作者
Park, Jung-Mi [1 ]
Lee, Eung-Ji [1 ]
Ramakrishna, Suresh [1 ]
Cha, Dong-Hyun [2 ]
Baek, Kwang-Hyun [1 ]
机构
[1] Pochon CHA Univ, Cell & Gene Therapy Res Inst, CHA Gen Hosp, Grad Sch Life Sci & Biotechnol, Seoul 135081, South Korea
[2] Pochon CHA Univ, Div Obstet & Gynecol, Seoul 135081, South Korea
关键词
polycystic ovary syndrome; single nucleotide polymorphism; 17 alpha-hydroxylase-17,20-lyase;
D O I
10.3892/ijmm_00000016
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Women with polycystic ovary syndrome (PCOS) are characterized by excess androgen secretion and anovulatory infertility as a cause of follicular maturation arrest, and they are also associated with insulin resistance and obesity. Recently, it was suggested that one of the etiologies for PCOS is an abnormality of steroid hormones, and excessive secretion of androgen. The endoplasmic reticular cytochrome P450, 17 alpha-hydroxylase (CYP17A), plays a key role in the mechanism of steroid hormones such as adrenal and gonadal steroid biosynthesis. Therefore, we studied the association between single nucleotide polymorphisms (SNPs) of the Al allelic variant of the CYP17 gene and PCOS in a Korean population. The study recruited 134 Korean women with PCOS and 100 healthy women as controls. Using the HapAnalyzer, the genotype of the CYP17Al polymorphism in PCOS and control patients were analyzed. We considered a p-value lower than 0.05 to be statistically significant. After genotypic analysis, we found seven SNPs of the CYP17Al gene in a large population of subjects. The frequency of seven SNPs had no significant association with PCOS. However, one haplotype (ht3) had a p-value of p=0.001, suggesting that it may be associated with the pathogenesis of PCOS in a Korean population.
引用
收藏
页码:249 / 254
页数:6
相关论文
共 26 条
[1]   Cytochrome b5 modulation of 17α hydroxylase and 17-20 lyase (CYP17) activities in steroidogenesis [J].
Akhtar, MK ;
Kelly, SL ;
Kaderbhai, MA .
JOURNAL OF ENDOCRINOLOGY, 2005, 187 (02) :267-274
[2]   Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome [J].
Apridonidze, T ;
Essah, PA ;
Iuorno, MJ ;
Nestler, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04) :1929-1935
[3]   POLYCYSTIC OVARIES AND PREMATURE MALE PATTERN BALDNESS ARE ASSOCIATED WITH ONE ALLELE OF THE STEROID-METABOLISM GENE CYP17 [J].
CAREY, AH ;
WATERWORTH, D ;
PATEL, K ;
WHITE, D ;
LITTLE, J ;
NOVELLI, P ;
FRANKS, S ;
WILLIAMSON, R .
HUMAN MOLECULAR GENETICS, 1994, 3 (10) :1873-1876
[4]   Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism [J].
Carmina, E ;
Rosato, F ;
Jannì, A ;
Rizzo, M ;
Longo, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (01) :2-6
[5]   Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome [J].
Chang, J ;
Azziz, R ;
Legro, R ;
Dewailly, D ;
Franks, S ;
Tarlatzis, BC ;
Fauser, B ;
Balen, A ;
Bouchard, P ;
Dahlgren, E ;
Devoto, L ;
Diamanti, E ;
Dunaif, A ;
Filicori, M ;
Homburg, R ;
Ibanez, L ;
Laven, J ;
Magoffin, D ;
Nestler, J ;
Norman, RJ ;
Pasquali, R ;
Pugeat, M ;
Strauss, J ;
Tan, S ;
Taylor, A ;
Wild, R ;
Wild, S ;
Ehrmann, D ;
Lobo, R .
FERTILITY AND STERILITY, 2004, 81 (01) :19-25
[6]   Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups [J].
Chang, WY ;
Knochenhauer, ES ;
Bartolucci, AA ;
Azziz, R .
FERTILITY AND STERILITY, 2005, 83 (06) :1717-1723
[7]   High incidence of molecular defects of the CYP21 gene in patients with premature adrenarche [J].
Dacou-Voutetakis, C ;
Dracopoulou, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (05) :1570-1574
[8]   Steroidogenic alterations and adrenal androgen excess in PCOS [J].
Doi, Suhail A. R. ;
Al-Zaid, Mona ;
Towers, Philip A. ;
Scott, Christopher J. ;
Al-Shoumer, Kamal A. S. .
STEROIDS, 2006, 71 (09) :751-759
[9]   Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome [J].
Ehrmann, DA ;
Liljenquist, DR ;
Kasza, K ;
Azziz, R ;
Legro, RS ;
Ghazzi, MN .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (01) :48-53
[10]   Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) [J].
Fauser, BCJM ;
Chang, J ;
Azziz, R ;
Legro, R ;
Dewailly, D ;
Franks, S ;
Tarlatzis, BC ;
Fauser, B ;
Balen, A ;
Bouchard, P ;
Dahlgren, E ;
Devoto, L ;
Diamanti, E ;
Dunaif, A ;
Filicori, M ;
Homburg, R ;
Ibanez, L ;
Laven, J ;
Magoffin, D ;
Nestler, J ;
Norman, RJ ;
Pasquali, R ;
Pugeat, M ;
Strauss, J ;
Tan, S ;
Taylor, A ;
Wild, R ;
Wild, S ;
Ehrmann, D ;
Lobo, R .
HUMAN REPRODUCTION, 2004, 19 (01) :41-47